GNMLF (Genomma Lab InternacionalB de CV) Construction In Progress: $0.0 Mil (As of Mar. 2026)


GNMLF Genomma Lab Internacional SAB de CV GNMLF
57 GF Score
Price $0.84
GF Value $0.99
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Genomma Lab InternacionalB de CV Construction In Progress?

Genomma Lab InternacionalB de CV GNMLF 57 Construction In Progress is $0.0 Mil as of Mar. 2026. GuruFocus rates GNMLF with a GF Score™ of 57/100 and a GF Value™ of $0.99 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Genomma Lab InternacionalB de CV's quarterly construction in progress increased from Sep. 2025 ($0.0 Mil) to Dec. 2025 ($16.7 Mil) but then declined from Dec. 2025 ($16.7 Mil) to Mar. 2026 ($0.0 Mil).

Genomma Lab InternacionalB de CV's annual construction in progress declined from Dec. 2023 ($48.8 Mil) to Dec. 2024 ($5.5 Mil) but then increased from Dec. 2024 ($5.5 Mil) to Dec. 2025 ($16.7 Mil).

Genomma Lab InternacionalB de CV Construction In Progress Historical Data

* Premium members only.

The historical data trend for Genomma Lab InternacionalB de CV's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomma Lab InternacionalB de CV Construction In Progress Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 122.57 77.51 48.76 5.46 16.69

Genomma Lab InternacionalB de CV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 16.69 0.00
GNMLF
57GF Score
Genomma Lab Internacional SAB de CV GNMLF
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genomma Lab InternacionalB de CV Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $0.0 Mil mean?
Genomma Lab InternacionalB de CV (GNMLF) has a Construction In Progress of $0.0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Genomma Lab InternacionalB de CV and its competitors.
Is Genomma Lab InternacionalB de CV's Construction In Progress too high?
Genomma Lab InternacionalB de CV's current Construction In Progress is $0.0 Mil. Overall, Genomma Lab InternacionalB de CV has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genomma Lab InternacionalB de CV's Construction In Progress compare to ZTS and UTHR?
Genomma Lab InternacionalB de CV's Construction In Progress of $0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Genomma Lab InternacionalB de CV and its competitors. Genomma Lab InternacionalB de CV's current Construction In Progress is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomma Lab InternacionalB de CV stock overvalued right now?
Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV (GNMLF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.99, compared to a current price of $0.84 — trading 15.5% below its estimated fair value. The current Construction In Progress is $0.0 Mil. Genomma Lab InternacionalB de CV's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Genomma Lab InternacionalB de CV (GNMLF), the current Construction In Progress is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genomma Lab InternacionalB de CV (GNMLF) Overvalued in 2026?

Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV stock appears to be undervalued. The current stock price of $0.84 is trading 15.5% below its estimated GF Value™ of $0.99. GuruFocus considers Genomma Lab InternacionalB de CV to be Modestly Undervalued.

Key valuation signals for GNMLF:

  • Construction In Progress: $0.0 Mil
  • GF Value™: $0.99 vs. price of $0.84 (15.5% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the GNMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genomma Lab InternacionalB de CV Business Description

Other Exchanges LABB:MexicoGEKA:Germany
Address Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
57GF Score

Get the complete analysis for GNMLF

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.84
Price
$0.99
GF Value